Emorecha, Jayson L.

HRN: 29-11-06  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/12/2026
06/19/2026
IV
1,500mg
Q 24 Hours
Nonresolving Pneumonia (ESBLE K. Pneumoniae)
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines